Vincent et al. [16] reported that a monoclonal antibody against VEGFR1 inhibited the proliferation and migration of primary multiple myeloma cells via plasma membrane retention of VEGFR1 following the prevention of its nuclear translocation. Here, FLT1 is linked to AL amyloidosis.